<code id='EB516EB0E9'></code><style id='EB516EB0E9'></style>
    • <acronym id='EB516EB0E9'></acronym>
      <center id='EB516EB0E9'><center id='EB516EB0E9'><tfoot id='EB516EB0E9'></tfoot></center><abbr id='EB516EB0E9'><dir id='EB516EB0E9'><tfoot id='EB516EB0E9'></tfoot><noframes id='EB516EB0E9'>

    • <optgroup id='EB516EB0E9'><strike id='EB516EB0E9'><sup id='EB516EB0E9'></sup></strike><code id='EB516EB0E9'></code></optgroup>
        1. <b id='EB516EB0E9'><label id='EB516EB0E9'><select id='EB516EB0E9'><dt id='EB516EB0E9'><span id='EB516EB0E9'></span></dt></select></label></b><u id='EB516EB0E9'></u>
          <i id='EB516EB0E9'><strike id='EB516EB0E9'><tt id='EB516EB0E9'><pre id='EB516EB0E9'></pre></tt></strike></i>

          entertainment

          entertainment

          author:knowledge    Page View:3
          Medicare is planning to send $9 billion in lump sum payments to more than 1,600 hospitals that participate in a drug discount program. Adobe

          WASHINGTON — Medicare is planning to send $9 billion in lump-sum payments to more than 1,600 hospitals that participate in a drug discount program after the Supreme Court found the program underpaid them for prescription drugs, the agency announced on Friday.

          To pay for the restitution, Medicare would slash all hospitals’ payments for other items and services by 0.5% for the next 16 years.

          advertisement

          The remedy accounts for four years of underpayments to hospitals that participate in the 340B drug discount program. The Trump administration dramatically reduced Medicare payments for discounted drugs in 2018, but the Supreme Court found they didn’t follow the proper procedure and that the payment scheme was illegal.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          How one medical school became remarkably diverse
          How one medical school became remarkably diverse

          ThefirstclassattheUniversityofCalifornia,Davismedicalschool,in1972,waspredominantlywhiteandmale.Chri

          read more
          Top private equity targets in 2023: cardiology, clinical trials, lasers
          Top private equity targets in 2023: cardiology, clinical trials, lasers

          AdobeBysomemeasures,privateequityinvestmentlaggedin2023,ayearmarkedbygrowingdistressandhigh-profiled

          read more
          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more

          Stories you might have missed in 2023: health, science, medicine

          Oneofourfavoritestoriesfeaturedoneofourfavoriteillustrations.MikeReddyforSTATThere’sanoldstoryinjour